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Parting Thoughts 
f r o m  t h e  O u t g o i n g  D e a n 
On June 1, the day after New 
York Medical College cele­
brates its 153rd Commence­
ment in Carnegie Hall, I will 
step down as dean of the 
School of Medicine. As I plan 
to tell some 362 graduates 
and their families and friends, 
the first time I went to medical 
school it took me only four 
years to get through; this time 
it required sixteen. You do slow down as you get older, but in 
my defense, medical education is much more complex today.
The 174 newly minted physicians of the Class of 2012 matched 
in twenty medical specialties at strong teaching hospitals 
around the country. We are very proud of our graduates; they 
will enhance the reputation of New York Medical College 
wherever they go. The about­to­enter Class of 2016 is shaping 
up as I write this. From more than 11,000 applicants, 1,400 
were selected to interview for admission to a class of 190. 
Their personal characteristics, diversity and academic creden­
tials predict a very strong class, and we are glad to note that 
our robust applicant pool—among the largest in the nation—
allows us to select the very best candidates. 
The last two years have presented the College with challenges 
and opportunities. When Saint Vincent’s Hospital in Manhattan 
closed in 2010, we were required to reassign 50 medical students 
to clerkships at other teaching hospitals and to place 300 
“orphaned” residents in GME programs. It was a monumental 
challenge that was successfully met thanks to the cooperation 
of our teaching affiliates, Westchester Medical Center and 
Metropolitan Hospital Center. Helping to ease the burden were 
new or expanded affiliations with Keller Army Hospital at West 
Point, Lenox Hill Hospital in New York City, Phelps Memorial 
Hospital Center in Sleepy Hollow, N.Y., and Saint Joseph’s 
Health Care System in Paterson, N.J. This complicated logisti­
cal exercise would not have been possible without the support 
of our clinical chairs, program directors and the good will of 
organized medicine. I want to express my gratitude to Paul M. 
Wallach, M.D., vice dean for medical education, Richard G. 
McCarrick, M.D., vice dean for graduate medical education 
and affiliations, and Gladys M. Ayala, M.D., M.P.H., senior 
associate dean for student affairs, for playing key roles in the 
effort, which provided the opportunity to explore new models 
for the curriculum.
The transition from sponsorship by the Archdiocese of New 
York to the Touro College and University System was com­
pleted this academic year. This historic undertaking was carried 
out in the best academic tradition of collegiality, with input from 
faculty, administration and students. Alan H. Kadish, M.D.,  
Touro’s president, was appointed president of New York 
Medical College. Following a nationwide academic search,  
a candidate was selected to lead New York Medical College 
into the future. We are all very pleased to inform you that on 
May 1, Edward C. Halperin, M.D., M.A., became chancellor  
for health affairs and chief executive officer of New York 
Medical College.
A graduate of Yale School of Medicine, Dr. Halperin completed 
an internship in internal medicine at Stanford and his residency 
at Harvard’s Massachusetts General Hospital. He spent 23 
years at Duke University, where he rose to become chairman 
of the Department of Radiation Oncology and vice dean of the 
School of Medicine. He also earned a Master of Arts in Liberal 
Studies there. Before coming to the College, Dr. Halperin was 
dean of the School of Medicine at the Univer sity of Louisville.  
I had the privilege of getting to know Ed when we were both 
serving on the Council of Deans. I can assure you New York 
Medical College is in very good hands.
Dr. Halperin will also serve as provost for biomedical affairs  
at Touro, and will serve as executive dean of the School of 
Medicine after I step down. With his ten years of experience as 
a medical school vice dean and dean, Dr. Halperin is eminently 
qualified to serve in this capacity until we begin a search for a 
new dean—probably in the coming academic year.
One of the first concrete (literally and figuratively) results of the 
Touro affiliation will be the construction of a new clinical skills 
center, which is expected to open in 2013. Watch for more 
news about this exciting development—and for more in future 
issues of Chironian, both about and by Dr. Halperin, a prolific 
writer and speaker who was chosen to deliver this year’s 
Commencement address.
In my final weeks as dean, I received numerous calls and visits 
from colleagues and students stopping by to say goodbye and 
wish me the best. With great tact, I told them that I planned to 
stay on the faculty, teaching in the Department of Psy chi atry 
and Behavioral Sciences. I have thoroughly enjoyed the honor 
and challenge of serving as dean and, prior to Dr. Halperin’s 
arrival, as provost. The best reward is the assurance that  
during my tenure, with the unwavering support of the Board  
of Trustees, department chairs, faculty and administration, 
approximately 3,000 individuals received M.D. degrees from 
New York Medical College, and are now in residency or prac­
tice, shaping the future of medicine.
Sincerely,
Ralph A. O’Connell, M.D.
Immediate Past Provost and Dean, School of Medicine
 An Expert at  
      Probing for Answers
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T he “War on Cancer” marked its 40th anniversary in December—a long time in anybody’s book, but not long enough to come up with a reliable cure for any of 
the thousands of symptoms that use uncontrolled cell growth 
to thrive. President Richard M. Nixon began using the metaphor 
in speeches to support the National Cancer Act, a historic bill 
passed at the close of 1971 to initiate federal government 
spending for cancer research. Scientists and physicians could 
approach their studies from the laboratory or by clinically treat­
ing patients with medicinal remedies specifically designed 
around their genetic make­ups in a process now called trans­
lational, or bench to bedside, treatment. At New York Medical 
College and affiliated Westchester Medical Center, there are 
nearly 20 investigators with M.D. and Ph.D. degrees who have 
spent their entire lives waging the war. One of them, Zbigniew 
Darzynkiewicz, M.D., Ph.D., has been point man at the cellular 
level, achieving world renown for his dogged pursuit of answers 
to a puzzle: how to turn cancer cells against themselves, 
instead of taking more human lives.
When a cell is damaged, chemical signals are activated that 
drive the cell to die without affecting nearby healthy cells. 
Knowing how to control this process, known as apoptosis, 
could allow doctors to control tumor growth with little, if any, 
toxicity to healthy cells. Research examining the differences 
between apoptotic and normal cells uses techniques that dif­
ferentiate between the molecular attributes of individual cells. 
Dr. Darzynkiewicz has the distinction of being a pioneer in the 
field, a man who has been at the forefront of cell cycle, cell 
proliferation, and apoptosis research since before he joined 
New York Medical College in 1990. In addition to directing  
the Brander Cancer Research Institute (BCRI), he also holds 
professorships in the departments of pathology, medicine,  
and microbiology and immunology. His research, which has 
earned him international repute, has been supported by grants 
from the NIH and the National Cancer Institute, including a 
prestigious MERIT award for his research on the effects of 
anticancer drugs on the cell cycle. He was also a recipient of a 
grant from NASA to develop new technologies for cell staining 
and analysis applicable to the micro­gravity conditions of the 
Space Station. He is the holder of eight U.S. patents, author  
or editor of 15 books, and has published nearly 700 peer­
reviewed articles.
COLLEAGUES IN CYTOMETRY
Frank Traganos, Ph.D., professor of experimental pathology 
and of medicine and associate director of BCRI, has worked 
with Dr. Darzynkiewicz for more than three decades and  
co­authored more than 120 papers with him. “He has made 
numerous contributions to our understanding of the processes 
and mechanisms underlying cell proliferation, cell death, and 
cell damage by investigating processes at the single cell level,” 
says Dr. Traganos. In 1992, the two collaborated with other 
colleagues on a paper published in Cytometry describing the 
By Alicia M. Prater, Ph.D. ’07
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Zbigniew Darzynkiewicz, M.D., Ph.D., develops the technology 
and methods for understanding cell proliferation, opening doors 
to more effective cancer treatment.
C H I R O N I A N  : :  New York Medical College  : :  03
molecular attributes that characterize apoptotic cells in flow 
cytometry. Now considered a landmark paper, it has been 
cited more than 1,500 times—and Dr. Darzynkiewicz has  
written a host of other papers with citations numbering in  
the hundreds.
He coined the term cell necrobiology, or the biology of cell 
death, and is credited with developing techniques for analyz­
ing cell kinetics, tumor progression and cell senescence. He 
discovered the basis for identifying a cellular resting phase 
known as “quiescent” or G0. Although his name is not quite  
a household word, he is perhaps best known for developing 
the TUNEL assay (TUNEL stands for terminal deoxynucleotidyl 
transferase dUTP nick end labeling), which remains one of the 
most widely used techniques for measuring apoptosis. But his 
work goes beyond simply trying to understand cell suicide. 
After earning his M.D. from the Medical University of Warsaw, 
Poland, in 1960, Zbigniew Darzynkiewicz earned the equiv­
alent of a Ph.D. on the basis of a thesis on the teratogenic 
actions of insulin in the chicken embryo. He developed a fasci­
nation with cell biology “because the analysis of molecular 
mechanisms in individual cells reveals the mystery of life.” His 
early work focused on developing new methods for studying 
enzymes in individual cells using radioisotope­labeled enzyme 
inhibitors. Two years later he accepted a position at the 
Karolinska Institute in Stockholm, Sweden, which, he says, 
“was the Mecca for cell biologists because of the capability to 
measure DNA and RNA content in individual cells.” 
ADVANCING METHODOLOGY
With the methods and equipment available at that time,  
Dr. Darzynkiewicz was capable of measuring 80 cells per 
day—a pittance compared to the thousands per second he 
measures now. Over the years the technology, and his capa­
bility, advanced with radioisotope labeling and autoradiography, 
and then with flow cytometry and fluorescent probes capable 
of identifying a variety of cell attributes. He expanded on each 
of these approaches to explore mechanisms underlying cell 
proliferation and the response of cells to anticancer drugs. 
In the late 1960s it was time to head for the U.S. There he  
held positions at SUNY Buffalo and the Boston Biomedical 
Research Institute before moving on to positions in New York 
at Memorial Sloan­Kettering Cancer Center and Cornell 
University Graduate School of Medical Sciences, where he 
met Dr. Traganos. “I was fascinated—not so much by the 
technology as with the biological problems this technology 
could help solve,” he says. In their early work together at 
Sloan­Kettering, Dr. Darzynkiewicz and Dr. Traganos evalu­
ated potential chemotherapeutic drugs in vitro, and their work 
today is still in vitro. Dr. Traganos explains that the cell­based  
work is important, because “if replicated, in vivo the findings 
would have broad applicability, even though it can take a long 
time to see clinical applications.” 
In the 1970s and 1980s, the understanding behind fighting can­
cer was to poison the malignant cells, which resulted in devas­
tating side effects that made cancer a word spoken only in 
hushed tones of dread. During this period, Dr. Darzynkiewicz’s 
lab successfully characterized the mechanism of action of 
anti­cancer drugs that were effective at lower doses, resulting 
in less toxicity to the patient than most of the drugs in use at 
that time. One of those drugs was mitoxantrone, which is cur­
rently used in the treatment of metastatic breast cancer, acute 
myeloid leukemia and non­Hodgkin’s lymphoma.  
GOING WITH THE FLOW
Shortly after being named director of the Flow Cytometry Core 
Facility at Sloan­Kettering he was recruited to New York Medi­
cal College. Zalmen Arlin, M.D., tapped Dr. Darzynkiewicz to 
head the College’s new Cancer Research Institute, founded 
the summer before to enable research in the etiology, classi­
fication, diagnosis and treatment of tumors. The key to this 
research would be flow cytometry, which allows variability 
among cancer cells to be evaluated in terms of their sensitiv­
ity to anticancer drugs. “The knowledge of such variability  
is essential in design ing clinical treatments that may be suc­
cessful in eradicating all cancer cells and thereby preventing 
cancer relapse,” says Dr. Darzynkiewicz. 
With flow cytometric measurements, apoptosis moved to the 
forefront. When damaged, normal cells become senescent, 
but tumor cells do not have the same ability to respond. Lack­
ing any damage control mechanism, they die via apoptosis, a 
pattern of events that is so orderly the process is often called 
programmed cell death. This difference can be exploited to 
increase the response to cancer treatment.
“New strategies are being developed and tested in pre­clinical 
studies to enhance the susceptibility of cancer cells to radia­
tion and DNA­damaging drugs by increasing their propensity 
for cell suicide,” explains Dr. Darzynkiewicz. “Attempts are also 
being made to force cancer cells to undergo ‘cellular senes­
cence,’ which permanently halts their reproductive capability.”
His lab is also studying the mechanisms in normal, non­tumor 
cells to understand resistance to DNA damage. The goal is 
the same as it has been for the past three decades: to ease 
the injurious side effects of radiotherapy and chemotherapy by 
reducing toxicity to healthy cells. 
Speaking with Dr. Darzynkiewicz, one gets the sense that new 
avenues in basic research are closely intertwined rather than 
disconnected areas of study. In the past his work has integrated 
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chemotherapy with apoptosis, and now it integrates cancer 
biology with the process of aging. 
Dr. Darzynkiewicz’s work in DNA damage also spans several 
decades. He was the first to show that the genetic defect in 
DNA repair in xeroderma pigmentosum can be corrected. And 
in 2010 he published work on double­stranded breaks and the 
carcinogenicity of tobacco smoke. His laboratory also detected 
constitutive DNA damage signaling as a consequence of oxi­
dative metabolism. He explains, “This oxidative DNA damage 
causes DNA replication stress which, when combined with 
cellular growth driven by the mTOR (mammalian target of 
rapamycin) pathway, is considered to be the major cause of 
aging and predisposes an individual to cancer.” In addition to 
rapamycin, the diabetes medication metformin and vitamin D 
are potential agents for suppressing the mTOR pathway. This 
suppression could create leaner and healthier cells, a context 
of aging currently being studied in Dr. Darzynkiewicz’s lab.
SETTING THE STANDARD
Without flow cytometry and similar techniques “the work  
Dr. Darzynkiewicz does would be decades behind,” says  
Dr. Traganos. His colleague agrees. “Without these tools, our 
research would be impossible,” Dr. Darzynkiewicz admits.  
His current work, supported by a grant from the NIH, aims to 
develop probes to study the DNA damage response and 
aging processes. He is already credited with developing 
probes identifying individual stages of the cell cycle to 
determine the mechanism of anti­cancer drugs. And many 
probes used world wide for detecting different stages of cell 
differentiation were developed by his lab, including acridine 
orange and BrdU incorporation into nucleic acids. “We are one 
step ahead because we’ve been developing the technology,” 
he says.
The probes used in cytometry can include different molecules, 
such as fluorescence­tagged antibodies or stains. The anti­
bodies used as probes can be specific for cell surface pro­
teins or indirectly labeled by a secondary antibody. Regardless 
of the type of probe, they are important in a variety of research 
areas and have a greater impact over time as more about the 
role of a particular protein in the cell is understood. Dr. 
Darzynkiewicz’s lab includes a cell sorter as well as a four­laser 
scanning cytom eter, both with multiple channels for detecting 
different types of fluorescence. 
In terms of sheer lab output, Dr. Darzynkiewicz ranks at the  
top of the fields of cell cycle, flow cytometry and apoptosis. 
He explains that his accomplishments in different areas of cell 
biology are due to the development of new methods for prob­
ing individual cells at the molecular level. With these methods 
cell growth, proliferation, carcinogenesis and response to anti­
tumor treatments can be studied. 
And in this, his thirty­third year of continuous funding,  
Zbigniew Darzynkiewicz, M.D., Ph.D., continues to probe  
cells for answers.  ■
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The Darzynkiewicz team is well acquainted with the sophisticated technology that aids in his research. From left are Frank Traganos, Ph.D., M.D./Ph.D. student 
Elise McKenna, Dr. Darzynkiewicz, Dorota Halicka, M.D., Ph.D., Jiangwei Li, Ph.D., and Jan Kunicki. Not pictured is Hong Zhao, Ph.D.
A re you among the one percent?The question is not about what you may think it is. It refers to  
the percentage of Americans who enjoy 
ideal cardiovascular health, according to 
a position paper released by the American 
Heart Association last March. The figure 
is actually less than one percent.
Heart disease is still the leading cause of 
death—not only in the U.S., but in every 
major developed country. The myth that 
it is primarily a man’s problem has also 
been debunked. In fact, more women’s 
lives are claimed by cardiovascular dis­
ease than by cancer, chronic respiratory 
disease, Alzheimer’s disease, and acci­
dents combined. When factoring in 
deaths from stroke, diabetes and other 
diseases that are related to problems 
with blood flow and blood pressure, the  
need for better understanding becomes 
even more critical.
An Huang, M.D., Ph.D., associate profes­
sor in the Department of Physiology, is 
studying one aspect of this challenge: 
the gender­specific regulation of endo­
thelial function in arterioles, the tiny 
blood vessels that branch out from arter­
ies throughout the body. Her research, 
supported by a series of grants from the 
National Institutes of Health, is part of  
a multi­faceted, multi­department pro­
gram at the College that pairs basic sci­
ence and clinical research in a quest to 
improve the outcomes in diseases that 
affect the heart and circulatory system.
FROM CHINA TO NEW YORK
The youngest of four children, An Huang 
grew up in the People’s Republic of 
China. Both of her parents were medical  
professors, so her interest in medicine 
developed early. But her path was tem­
porarily derailed by the harsh reforms of 
the Chinese Cultural Revolution. At the 
time she graduated from high school, 
many students were being forced out of 
cities and effectively exiled to work in 
factories or farms, rather than going to 
college. In 1977, after these policies 
changed, Huang was among the first 
group of students allowed to enter college. 
She received her M.D. from Shanghai 
Second Medical University in 1982 and 
was directed by the government to enter 
the practice of general surgery.
By the time China began to open to the 
outside world in 1990, Dr. Huang had 
earned an M.S. and a Ph.D. in surgery. 
Feeling that she’d advanced in her pro­
fession as far as she could in her home 
country, she was eager to see what she 
  
Pieces of the 
Cardiovascular Puzzle
An Huang, M.D., Ph.D., studies estrogen, blood flow and blood 
pressure, and how they fit together.
By Cynthia A. Read
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might learn elsewhere. Although she was 
still thinking about pursuing her clinical 
interests, she landed a position as a 
research fellow in the Depart ment of 
Physiology in 1992. And, in what she 
calls “one of the luckiest moments in my 
life,” she met the late Gabor Kaley, Ph.D., 
who served for 37 years as chairman  
of the Department of Physiology. “He 
taught me everything about research,” 
she says. “It was my great honor to be 
able to work with Dr. Kaley. It would have 
been impossible for me to become an 
established scientist without him.”
The College brought Dr. Huang an addi­
tional gift: Dong Sun, M.D., who was  
also a product of the first wave after the 
Cultural Revolution, was then a Ph.D. 
student under Dr. Kaley. The two came 
halfway around the globe to meet on the 
Valhalla campus, and married in 1994. 
After their daughter Angela was born in 
1996, Dr. Huang brought her to work  
in her bassinet when she was only a 
month old so the family research proj­
ects could continue.
GENDER DIFFERENCES
Beginning with her first research projects 
with Drs. Kaley and Sun, along with Akos 
Koller, M.D., Ph.D., professor of physiol­
ogy, Dr. Huang has investigated microcir­
culation—the term for the small blood 
vessels embedded in organs that are 
responsible for the distribution of blood 
within the organ tissues and for maintain­
ing blood pressure. The arterioles carry 
blood to the capillaries and, like all blood 
vessels, are lined with a thin layer of cells 
comprising the endothelium. Among the 
many functions of endothelial cells are 
controlling the dilation and constriction  
of the arterioles.
Hypertension from overly constricted 
blood vessels increases the workload  
on the heart, leading to thickening of the 
heart muscle (myocardial hypertrophy), 
often followed by heart failure. Women 
have a bigger vasodilator response than 
men and, before menopause, a lower  
risk of heart disease. It appears that estro­
gen is responsible. When the ovaries  
are removed from experimental animals 
such as rats, the females have a reduced 
dilator response, but if the same females 
are given estrogen after ovariectomy, the 
dilator response returns.
In their initial studies, Dr. Huang and her 
collaborators explored the mechanisms 
of nitric oxide (NO) in dilating arterioles in 
rats and mice. When synthesized in the 
endothelium of blood vessels, nitric oxide 
is also called endothelium­derived relax­
ing factor, so named for its ability, when 
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released from the endothelium, to signal 
the surrounding smooth muscle to relax. 
This dilates the vessel and increases 
blood flow, therefore decreasing blood 
pressure. The team showed that estro­
gen increases the expression and activity 
of eNOS, the enzyme that synthesizes NO. 
Genetically modified mice that lack the 
gene to produce eNOS, and therefore 
lack nitric oxide, are hypertensive—yet 
still, female mice have better regulation of 
blood pressure than males do.
So Dr. Huang’s next step was to study 
how estrogen affects the dilation of 
blood vessels independent of the activity 
of nitric oxide. She discovered additional 
endothelial mediators were dependent 
on cytochrome P450 (CYP). She has 
also learned that different forms of CYP 
are responsible for the release of other 
vasodilators in rats, mice and humans. 
Because this sequence seems specific 
to females, Dr. Huang has begun to 
explore why these gender difference  
exists, which genes are involved, what 
earlier influences come into play, and 
how changes in vasodilation, and there­
fore in the regulation of blood pressure,  
are related to aging associated with 
menopause.
“All the expertise I need is here at 
NYMC,” she says. She continues to col­
laborate with her husband and with  
co­investigator Caroline Ojaimi, Ph.D., 
assistant professor of physiology. She 
also receives support from Edward J. 
Messina, Ph.D. ’73, professor, and 
Thomas Hintze, Ph.D. ’80, professor and 
chairman of the Depart ment of Physiology, 
as well as other members of the depart­
ment. Dr. Messina says, “It has been a 
pleasure and an honor to watch the 
growth of Dr. Huang as an independent 
investigator. I am impressed with her 
research success, which has offered 
important clues to our understanding  
as to why premenopausal women are  
somewhat protected from cardiovascu­
lar events. She has also provided signifi­
cant evidence on the relevancy of the 
microcirculation in vascular biology and 
medicine.”
LOOKING AHEAD
Dr. Huang thinks that better understand­
ing the mechanisms by which estrogen 
regulates the dilation of blood vessels 
could lead to improved treatment for 
menopausal women, and her research 
could point to a new therapeutic target 
to improve cardiovascular function where 
NO is deficient.
That is down the road, however. For 
now, Dr. Huang relies on a motto of 
sorts: “Be solid at every step,” she says, 
“keep going, and never give up.” It has 
served her well, not only in her years of 
research at New York Medical College 
but in the life journey that brought her 
more than 7,000 miles from Shanghai  
to Valhalla.  ■
“ All the 
expertise I  
need is here  
at NYMC.” Assisting Dr. Huang in her study of gender-specific regulation of endothelial function in arterioles are, from left: Dong Sun, M.D., Ph.D., Hongyan Wu, technician, and Caroline Ojaimi, Ph.D.
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3:  Trustee Ronald F. Poe, President Alan Kadish, M.D., 
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8:  School of Medicine graduates capture the excitement 
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Music and       Medicine
Stephen E. Moshman, M.D., 
     gives equal time to his main passions.
Making a Menu for Life with
} }
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By Marjorie Roberts
T he Department of Medicine is a challenging and exceptional place to work. Many members of the fac­ulty were recruited to the Valhalla campus by friends 
and colleagues from their previous lives. A case in point is 
Stephen E. Moshman, M.D., who radiates energy, caring and 
collegiality on a daily basis—weekends included. This not only 
enables him to perform an unusual variety of tasks for his job, 
but also allows him to have a second life filled with music. This 
spring, his dual passions for teaching and music became a 
perfect storm that honored Dr. Moshman for both his roles. He 
was promoted to Professor of Clinical Medicine, a title he will 
cherish in recognition of his 43 years of service to medicine—10 
at the College and Westchester Medical Center (WMC)—and 
gratification for acknowledgement of his 30th anniversary year 
as founder, composer, and conductor of the Albert Einstein 
Symphony Orchestra, serving the Bronx community through 
the talents of 60 mostly non­professional musicians with a 
concert agenda each year.
Medicine inspires him to teach, for Moshman a sacred word 
that covers everything he does for the young heroes who follow 
in his path. As director of the third­year medicine clerkship, he 
has mentored students who are learning to make critical  
decisions that will impact how they practice medicine the rest 
of their lives. “My greatest passions are medicine and music, 
but I am ardent about a lot of things,” he admits, and he is  
not exaggerating. The mere mention of baseball, history and 
astronomy causes his eyes to light up and his voice to rise  
in intensity.
You can only wonder how he is able to find the spiritual 
wherewithal and physical strength to staff, rehearse and con­
duct the Einstein orchestra in four concerts a year. Ask him, 
and this Renaissance man replies, “I can do it because I am  
a very happy man.”
BEING HAPPY
How happy is he? Enough to spar with the colleague who 
recruited him from Einstein and its affiliated Montefiore Hospital: 
William H. Frishman, M.D., the Barbara and William Rosenthal 
Professor and Chairman of Medicine. They were both faculty 
members at Einstein, where Moshman spent 30 years before 
coming to the College. They take their sworn allegiance to  
differing New York baseball teams as set in stone, yet their 
Music and       Medicine
Stephen E. Moshman, M.D., 
     gives equal time to his main passions.
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love of the game is reason enough to sustain their friendship. 
“Baseball is the only sport. I come alive when pitchers and 
catchers report for spring training,” says Moshman, a former 
Brooklyn Dodger fan. He is ready to take on another frus­
trating year as a Met supporter, but he wouldn’t want it any 
other way.
Robert G. Lerner, M.D., vice chairman of the Department of 
Medicine at the College and chief of hematology at WMC, 
shares Moshman’s double appreciation of teaching and music. 
The Moshmans and Lerners, who have enjoyed many perfor­
mances of the Einstein Orchestra, also attend Lincoln Center 
events together. “I have been very impressed with everything 
he’s done,” says Dr. Lerner, although it is Moshman’s work 
ethic that draws Lerner’s greatest interest and admiration.  
“I got to know him better when he and I began teaching  
second­year students along with his brother, Eliot Moshman, 
[M.D., clinical assistant professor of medicine], an internist in 
White Plains who plays French horn in the orchestra.”
There is also Norma Moshman, Stephen’s wife, who is coordi­
nator for the Internal Medicine Residency Program. Together 
the Moshmans make up a sort of parents­by­proxy situation, 
which makes it seem like there are Moshmans everywhere. 
Stephen claims he never repeats a task two days in a row, but 
certain responsibilities are his alone. He teaches “Foundations 
of Clinical Medicine,” a mandatory course for first­ and second­
year students. And there is “Harvey,” a favorite mechanism 
that involves an inventive way to teach, sometimes using musi­
cal sounds for emphasis.
AN APPRECIATIVE COLLEAGUE
The Harvey Cardiopulmonary Patient Simulator is a digital life 
size model of a patient with lots of heart problems, which can 
be dialed up at will. Cardiac pathology and proper diagnosis 
are the basic skills that Harvey helps teach to third­year stu­
dents, pre­internship students, interns and residents.
Among Dr. Moshman’s other purviews are the residency  
program in internal medicine where he is deputy director,  
the Adult Primary Care Clinic and his teaching duties in the 
Pre­Internship Program, formerly called the Fifth Pathway. As to 
the variety of situations in which he finds himself, Dr. Moshman 
expresses his satisfaction with volunteering for unscheduled 
teaching assignments by insisting that, “I have always consid­
ered myself a militant non­specialist. I accept these assign­
ments with enthusiasm. After all, teaching medicine is 75 
percent of what I do and I absolutely relish it all.” Dr. Frishman 
concurs: “We go back 40 years. Currently, every July, he and  
I share the welcoming lectures for the new clerkship students 
and we teach together on the wards at WMC. He is also very 
active in recruiting house staff for Valhalla.”
When pre­concert time rolls around, you wouldn’t know from 
his disposition that he was stressed. Norma Moshman, who 
sounds as laid back as the husband she is describing, offers 
this assessment:
“For the most part he is very relaxed. He doesn’t worry. He 
may have trepidations about a certain passage the orchestra 
is having trouble with, but in 30 years the orchestra has never 
failed him.” Any changes planned for season 31? “He doesn’t 
wear tails and the musicians just wear black jackets, although 
at the March concert the orchestra wore what is called 
Broadway Black. Stephen wore a silver tie and they all really 
looked good. Now they are considering wearing Broadway 
Black all the time.”
NATURAL BORN TEACHER
In both the classroom and the orchestra pit, Stephen 
Moshman dictates what happens from the moment he walks 
into the room. In between he gets as close as he can by 
becoming an excellent teacher who, like any good performer, 
makes things exciting. A slew of teaching awards attest to his 
tremendous teaching talents and famous sense of humor. But 
can he continue to do everything himself? With the orchestra, 
this encompasses making the selections to be played (many 
are his own compositions), choosing the soloists and even 
writing the program notes before he rehearses the musicians 
and conducts the day of the performance. He has been 
In both the classroom and the orchestra pit, 
Stephen Moshman dictates what happens from the 
moment he walks into the room. }}
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immersed in this medical/musical arrangement all his life,  
and there is one doctor/musician who has been a part of  
most of it.
Etta Eskridge, M.D., Ph.D., now an assistant professor of med­
icine at the College, was 22 when she met Steve Moshman. 
Both had earned their undergraduate degrees at the University 
of Rochester; she chose Einstein for medical school while he 
selected the University of Buffalo. She found out he was 
looking for musicians for a new orchestra he was assembling 
and she played the viola, a rare commodity in terms of slots to 
be filled. The rest, since 1982 and then some, is history. Four 
years ago Dr. Moshman recruited her to join Westchester 
Medical Center, where she is a hospitalist and director of 
palli ative care.
“He is like a savant,” she says of Moshman. “He is a walking 
encyclopedia of knowledge, and he writes the best program 
notes ever…He has given all of us an unbelievable gift—the 
opportunity to play music—and we do a pretty good job.” This 
past season there were six players from New York Medical 
College; about one­third of the group are medical students, 
faculty and house staff, and the rest are from the community. 
Dr. Moshman believes his is one of the longest running com­
munity orchestras in the city, and “certainly, the only medical 
school­affiliated orchestra.”
Dr. Moshman has established that even in his spare time, he is 
devoted to the students who are his audience—in and out of 
hospital settings. Just as he learned to play the violin from his 
father, his first teacher who made music such an integral part 
of his upbringing, he makes himself available to those who 
need help—even  the ones who come around only when he 
hosts his annual pool party at his Dobbs Ferry, N.Y., home 
(which, by the way, was designed by a student of Frank Lloyd 
Wright). The party is Dr. Moshman’s way of plying his guests 
with art and the finer things in life. He has no ulterior motive for 
this gesture, and no message is intended or implied—other 
than to enjoy life and art, which are all around us.  ■
}
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Its proponents claim the use of new media in medicine is 
a boon, causing shifting paradigms, seismic changes, and 
better connections online and off.
Is MEDICINE Ready   
for Social Media?
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Twitter, tablets, texting: these are means and methods of social media now surging in popularity. 
They are also revolutionizing medical 
practice and education, including  
at New York Medical College. From 
three­dimensional views of anatomy  
to classroom discussions sparked by 
text­messaging, the wealth of material 
summoned by a few finger­taps helps 
educators share and receive critical 
findings, more fully engages students 
with the curricula, and helps doctors 
build stronger connections, online and 
off, with patients.
“Why am I on social media? Because 
I’m social,” says Howard Luks, M.D. ’91. 
The associate professor of orthopedic 
surgery at the College and chief of 
sports medicine and arthroscopy at 
Westchester Medical Center likes to 
add, “That means sincere, open, collab­
orative, interested, authentic, and like­
able.” (He’ll admit the acronym is not 
original, but it’s been re­tweeted many 
times behind his Twitter handle, @hjluks.) 
Dr. Luks writes several blogs on ortho­
pedic surgery and social media, has 
5,000 Twitter followers, and offers iPads 
in the exam room with videos to edu­
cate his patients. “Why confine my 
expertise to the four walls of my prac­
tice?” he asks.
For doctors and patients alike, social 
media is triggering a paradigm shift in 
health care. Pew Surveys show that  
17 percent of mobile phone users are 
using them for health care purposes, 
and 44 million health apps were down­
loaded in 2011. Even the prestigious 
Mayo Clinic in Minnesota has started a 
Center for Social Media to train physi­
cians in social media strategy.
“When I first started to meet with groups 
about social media in medicine, their 
eyes were rolling,” recalls Dr. Luks. “They 
thought it meant posting what you had 
for dinner or checking in at Starbucks. 
But as in all professions, the immediacy 
and interactivity of social media helps 
us clinicians humanize our presence 
and foster our relevance in a world 
that’s increasingly going online.
“They’re talking about us, talking about 
health,” he declares. “Now it’s up to us 
to jump into that conversation. If we 
don’t control our own message, others 
will define who we are.”
The College has been doing its part to 
join in. In April, the annual Student Physi­
cian Awareness Day (SPAD), organized 
by first­year medical students, was 
devoted to exploring “iMedicine: The 
Role of Social Media in Medicine,” with 
renowned experts convening to discuss 
how social media is altering the nature 
of patient care, medical education and 
community outreach. The event was 
well­attended, and in social media (or 
SoMe) parlance, there was a great deal 
of chatter and following activity that 
nudged the College’s profile a bit higher 
in the Twittersphere.
Among the speakers was Kent Bottles, 
M.D., who serves as the social media 
liaison for the Association of American 
Medical Colleges. “Most older medical 
educators like myself are ‘digital immi­
grants’ who still speak the new language 
with an accent,” says Dr. Bottles, a 
Senior Fellow at The Thomas Jefferson 
University School of Popula tion Health 
in Philadelphia. “It is the medical stu­
dents who are the digital natives that 
are really leading the way. I think it’s  
relevant that the topic was introduced 
[to NYMC] at a medical student confer­
ence and not by faculty.”
TRANSFORMING MEDICINE
Resources for doctors. Smart phones 
and tablets, equipped with task­specific 
programs (called “apps”), make a wealth 
of clinical information and references 
readily available on a portable screen. 
Among College faculty, popular apps 
include Epocrates RX, a mobile drug 
reference database, Medscape, a medi­
cal reference guide, and Diagnosaurus, 
a database of diseases and symptoms.
Resources for patients. Social media 
is changing the doctor­patient dynamic: 
how doctors reach out and what kinds 
of information patients bring into the 
office or hospital. Apps can help doc­
tors engage with their patients by dem­
onstrating procedures using 3­D views 
of anatomy, displaying test results, and 
sending text message reminders of 
appointments and vaccinations. In 
between office visits, doctors and 
By Melissa F. Pheterson
Is MEDICINE Ready   
for Social Media?
C H I R O N I A N  : :  New York Medical College  : :  15
patients can communicate directly via text or Twitter messages, or even brief video 
messages, the form preferred by more than half of the patients Dr. Luks surveyed. 
“Email,” he says, “is passé.” 
Telemedicine, the concept of caring for patients remotely, is also gaining ground.  
Dr. Bottles cites research predicting that by 2016, three million patients will be moni­
tored via their smartphones, rather than in hospitals, for chronic conditions like heart 
disease and diabetes.
Social media can empower the patient without imperiling the doctor, stresses  
Dr. Bottles. “Some patients want to record their interactions during office visits, but 
many physicians are reluctant to embrace social media because of fears of malprac­
tice suits,” he says. “And yet, studies have shown that patients retain only 50 percent 
of what the doctor tells them during an office visit, and half of what the patient does 
remember is remembered incorrectly.”
So instead of fearing the patient who comes in with reams of information printed from 
the Internet, doctors can seize the chance to guide patients as they search for repu­
table articles, e­mail information after appointments, or maintain a blog or website 
with concise answers to common questions. Says Dr. Luks: “Some doctors will shy 
away from a patient coming in with material they’ve Googled, whereas I’m turning on 
the iPad, hitting Google, saying ‘There are 600 articles on medicine published every 
day; let’s see if anything was posted today that’s pertinent to your case.’” 
Resources for both. Increasing numbers of clinicians and researchers have now 
launched Twitter accounts, whereby they can issue brief messages called tweets to  
a group of followers, comprising doctors and patients alike. Tweets might include 
links to new medical findings, spotlight topics posted by other experts, or offer 
advice on medical issues or healthy living. More than 1,300 physicians have now  
registered their Twitter feeds on twitterdoctors.net, and communities are emerging 
online among doctors (Doximity.com, a social networking site for physicians) and 
patients (PatientsLikeMe.com, a forum for people with similar health conditions to 
support and advise each other).
BEYOND THE CLASSROOM
One morning before class, Daniel Peters, M.D., F.A.C.S., assistant professor of cell 
biology and anatomy, noticed his students deeply absorbed in their phones. “It was 
clear that almost everyone was texting away furiously, trying to get out that last mes­
sage before class started,” Peters says. He also noted these same students hadn’t 
yet responded to emails he’d sent a few days earlier. “I realized that email was obso­
lete to them: in their world, it served no purpose and it was too slow and inefficient 
for real­time needs.” But a text or tweet would pop up instantly on their phones, 
compelling them to respond. As an experiment, Peters began to send messages to 
the class via Twitter, posing questions and offering points for reflection to spur critical 
thinking and discussion among his students.
“Twitter allowed me to put ideas in their heads outside of class, when they might be 
together in some social situation, and use the opportunity to have an open and free 
discussion,” he says. “I was also trying to show that they always had to be think­
ing—the thought process does not, and should not, stop as soon as class is out.” 
16 : :  Spring/Summer 2012
Photo by Susan Woog Wagner
Among students, the study groups 
known as “journal clubs” now benefit 
from instant access to groundbreaking 
news in medicine, with Twitter alerts 
outpacing the snail’s­paced peer­review 
model that produces journals.
 “Physicians and researchers in far­flung 
locations can discuss articles and 
exchange knowledge instantly,” says 
first­year medical student Neil Shah, 
chair of the committee that organized 
SPAD. “The flow of information is the 
biggest way social media has helped 
improve academic medicine.” 
For institutions like New York Medical 
College, social networking sites also 
provide an opportunity to reach out to 
prospective students, current students 
and alumni. The Office of Public Rela­
tions, responsible for the College’s offi­
cial social media presence, is now 
encouraging other departments and 
groups to establish their own presence 
in social media, using guidelines posted 
on the College’s website. 
“Curating and sharing information with 
an audience of followers on social 
media is a way to engage people, and 
get them talking with us about some­
thing that is of interest to them,” says 
Donna Moriarty, M.P.H. ’04, associate 
vice president of communications, who 
posts Twitter and Facebook updates on 
behalf of the College several times per 
week. “The institution becomes more 
real to them, more personal, through 
social media activity. It’s a way to 
spread news to our students and 
employees about what is happening 
here, and offers a window for prospec­
tive students, parents and alumni to 
peer through and see what we’re up to.” 
RED FLAGS
In the uncharted waters of social media, 
new ethical and legal dilemmas can 
pose unexpected hazards. Should doc­
tors or professors initiate and accept 
“friend” requests from patients or stu­
dents? What if a patient solicits medical 
advice online that ends up flawed? 
What if a medical student or resident 
posts descriptive comments of a clinical 
experience, inadvertently violating HIPAA 
rules governing patient privacy? These 
issues are a “major concern,” says Shah, 
but doctors, professors and institutions 
can protect themselves by educating 
students and patients about the perils 
of social media. “Anyone using social 
media,” says Kent Bottles, “needs to 
think about the permanent and public 
nature of anything on Twitter and 
Facebook.” Howard Luks emphasizes 
that he doesn’t treat patients via social 
media, only shares information. The 
American Medical Association has 
released social media guidelines sug­
gesting that doctors use the maximum 
privacy settings for each mode of online 
communication, and consider using 
separate profiles for personal and pro­
fessional use. Many hospitals and prac­
tices now raise the issue with patients 
as soon as they check in, presenting a 
contract with waivers or disclaimers.
“Once I learned about social media, I 
realized the user has controls,” says 
Anthony Sozzo, M.A., M.S.Ed., associ­
ate dean for student affairs, who main­
tains a popular page on student financial 
planning, and who has produced pod­
casts and YouTube video clips for, and 
with, the students. “You can still main­
tain a professional presence on social 
media.” That synthesis of clinical excel­
lence and social media was among the 
major objectives at SPAD, with a live 
Twitter feed enhancing discussion and 
debate even further.
"Because of SPAD, the College will gain 
a significant amount of attention, kudos 
and support,” says Dr. Luks. If it means 
dissolving the barriers to communica­
tion, then New York Medical College 
has added a few more instruments to 
its black bag.  ■
Which social media platform do 
you use: Facebook, Twitter, 
LinkedIn, YouTube or Google+?
IN A FACULTY SURVEY, 85 RESPONDENTS WERE ASKED:
33.3%
10.3%
40.2%
43.7%
34.5%
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BEYOND 
SKIN 
DEEP 
In learning to treat the 
skin—the mirror of 
internal diseases—
dermatology residents 
inject dermatologic 
care into a host of 
other specialties.
18 : :  Spring/Summer 2012
 I n 1993, Bijan Safai, M.D., professor of dermatology, took over as chairman of the Department of Dermatology at  New York Medical College in Valhalla. Several years later, 
he moved the residency program from Westchester to upper 
Manhattan’s Metropolitan Hospital Center, a public hospital 
and College affiliate that treats many underserved patients. 
This move turned out to be a boon for both the residency  
program and the patient population it serves.
“I brought the residency to the patients,” says Dr. Safai. By 
that he means that taking care of a more diverse, inner city 
population gives the future dermatologists under his tutelage 
an opportunity to treat the full spectrum of clinical diseases. 
The residents care for everything from acne to leprosy to toxic 
epidermal necrolysis (TEN), a potentially deadly skin disease 
that usually results from a drug reaction.
There are other benefits as well. “One of the great things about 
working at Metropolitan Hospital is that we see patients from 
varied ethnicities,” says first­year resident Lavanya Krishnan, 
M.D., one of 10 residents currently enrolled in the College­
sponsored program. Many skin diseases, she explains, pre­
sent very distinctively in different types of skin. For example, 
rashes that appear on deeply pigmented skin tend to be more 
subtle or textured. If a doctor isn’t well­versed in these skin 
differences, making an accurate diagnosis can be especially 
challenging.
Residents’ learning touches on the entire spectrum of medical 
dermatology, including immunologic diseases of the skin, 
cutaneous lymphomas and sarcomas, drug eruptions, genetic 
syndromes affecting the skin, and dermatologic emergencies. 
They also learn how to perform laser surgery, Mohs micro­
graphic surgery, blepharoplasty and skin cancer removal. In 
short, they learn it all. “We could write a textbook” with the 
By Nelly Edmondson Gupta
experiences she and the other residents gain from treating 
patients, says Jodi Langer, M.D., who serves as co­chief resi­
dent with William Rietkerk, M.D.
MANY CALLED, FEW CHOSEN
Considered among the nation’s best, the New York Medical 
College dermatology residency program is very competitive. 
From more than 300 applicants, just three are chosen annu­
ally. To be selected, says Dr. Safai, a resident “must have an 
intelligent mind and be able to quickly retrieve and grasp a lot 
of information.” She or he also must be a clear thinker, a good 
writer and an effective “people person.” Finally, says Dr. Safai, 
residents must be able to learn independently and be good 
team players.
In fact, the competition for dermatology residency slots has 
become increasingly stiff nationwide. “When I took over, resi­
dents were mostly selected from the New York area,” says  
Dr. Safai. “Now we get the best applicants from all over  
the country.”
In addition to working with a wide variety of interesting patients, 
one of the best things about the NYMC program, say the resi­
dents, is the solid grounding in both clinical work and pathology. 
“One of the things that initially attracted me to NYMC was this 
clinical­pathologic correlation,” says first­year resident James 
Highsmith, M.D. In other programs, he explains, residents may 
learn to read pathology slides, but not necessarily the slides 
they themselves have prepared from biopsies. “It’s nice to see 
the clinical picture—your patients—and then review their biopsy 
slides under the microscope,” says Dr. Highsmith. “It really 
helps you learn and remember.”
TEACHER, TEACH THYSELF
Yet another draw for the NYMC program is the fact that all 
dermatology residents have plenty of opportunities to teach  
as well as learn. Each week the residents complete multiple 
academic duties, including journal reviews of medical and sur­
gical dermatology, Kodachrome sessions (clinical slides used 
for diagnostic practice), pathology training and book review 
lectures. The residents take turns delivering lectures to their 
peers on topics in the main textbook. In order to answer ques­
tions and provide background and context, the designated 
lecturer must go beyond the text, thereby deepening his or  
her knowledge base.
The dermatology residents also teach medical students and 
give lectures to other departments. “Medical students have a 
limited exposure to dermatologic disease during med school, 
but many other specialties, such as internal medicine and 
pediatrics, need significant knowledge about the skin,” explains 
Richard McCarrick, M.D., vice dean for graduate medical  
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education and affiliations. “So they rely on the dermatology 
residents to build their knowledge of skin diseases.”
Although relatively few patients are admitted to hospitals solely 
because of skin conditions, they may have skin problems in tan­
dem with other disorders. For example, a psychiatric patient may 
be admitted in crisis, and a subsequent physical exam reveals a 
rash or severe lesions on his lower back. Having dermatology 
residents available for consult enables the psychiatric team to 
provide comprehensive care. “There is a tremendous benefit 
to having a derm residency in a hospital that goes far beyond 
treating patients who present with primary skin problems,” says 
Dr. McCarrick. “Throughout the hospital, having derm residents 
and attendings is clinically and educationally very helpful.”
The residents truly must learn to master the art of diagnosis in 
order to recognize underlying systemic conditions. In fact, the 
residents and their supervising attending physicians provide der­
matologic consultation for all inpatient services and ambulatory 
care programs. They have to know the basics of internal medi­
cine, pediatrics, neurology, surgery and psychiatry to be able to 
competently integrate dermatologic care into all of these fields.
IT’S NATIONAL AND PERSONAL
Indeed, dermatology has been getting more respect from all 
quarters lately, and is now the most competitive specialty. In 
recent years, many American medical school graduates have  
been migrating away from primary care and general surgery. As 
a recent article in The New York Times noted, dermatology—like 
plastic surgery and otolaryngology—provides relatively controlla­
ble hours, autonomy, and improved quality of life, and has the 
added benefit of being the kind of doctor patients actually like 
and want to visit.
Second­year resident Kathryn Russell, M.D., says that while she 
was growing up in Sarasota, Fla., her dermatologist “was the 
only doctor I enjoyed going to.” Every year, her mother took 
fair­skinned, redheaded Kathryn to a dermatologist for a full­
body skin exam; the Russells have a family history of skin can­
cer and Kathryn is at increased risk. Instead of dreading these 
medical visits, she actually looked forward to learning about 
her skin, hair and nails during her examinations. Dermatology 
“is a very fulfilling field because patients really appreciate you,” 
she says. “You treat them, and they look better—and feel bet­
ter about themselves.”
HAVING SKIN IN THE GAME
“There’s a whole list of reasons to go into dermatology,” says 
second­year resident Robert Lott, M.D. He points out that 
research in the field of cutaneous immunology and molecular 
biology of skin is moving at a rapid pace. “As a result, we are 
developing a better understanding of the immunologic and 
molecular pathogenesis of skin disease leading to optimized 
diagnosis, management and treatment of patients,” he says.
Dermatology director and department 
chair Bijan Safai, M.D., above, says 
the highly competitive program at 
New York Medical College admits 
only three new residents per year. 
Residents Lavanya Krishnan, M.D., 
and William Rietkerk, M.D., prepare  
to treat a patient at Metropolitan 
Hospital Center.
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• A REAL HONOR  
In February, Dr. Safai was elected president of the Physician Affiliate Group of New York (PAGNY), made up of more than 2,500 phy sicians 
and health care professionals who provide services to the half dozen hospitals that comprise the New York City Health and Hospitals 
Corporation (HHC), the largest public health system in the U.S. “It is quite an honor for me to be trusted by my colleagues and elected as 
president of such an important organization,” Dr. Safai says.
These new developments are helping researchers create 
“designer drugs” for the treatment of skin­related autoimmune 
diseases, like psoriasis. “Many systems collide in the skin,” 
notes co­chief resident Langer. “The skin is a mirror of internal 
diseases, with sequelae from immunologic, neurologic, infec­
tious, endocrine and neoplastic processes.” This “collision”  
is evident in many systemic diseases, such as lupus, some 
cancers, hypercholesterolemia and liver disease, which often 
show up first on the skin. In other words, adds Dr. Langer, 
“The research we’re doing on skin may have greater applica­
tions beyond the skin.”
Each year, every NYMC dermatology resident must undertake 
an intensive research project. This year, they are studying  
a broad array of topics, including polymorphisms of non­ 
melanoma skin cancers, skin stem cells, which can be  
used for growing hair and curing some of the blistering dis­
eases of childhood, and skin manifestations of graft vs. host 
disease, a serious condition that can develop after bone  
marrow transplantation.
“Dermatology is a rapidly evolving field, and cutting­edge in 
terms of new technology,” adds Dr. McCarrick. “Dermatologists 
are in great demand, and there’s a shortage in many parts of 
the country.”
Drs. McCarrick and Safai believe this group of residents will 
become experts and leaders in the field. Every year, says  
Dr. Safai, he continues to be pleasantly surprised. “Our der­
matology residents are committed and diligent, and they are 
here to learn. They study hard, help each other and work well 
as a team.”  ■
Residents gather weekly for peer-teaching sessions. Clockwise from the presenter, Pantea Hashemi, M.D., are Jodi Langer, M.D.; David Weinstein, M.D.; Jennifer 
Leininger, M.D.; Lavanya Krishnan, M.D.; Robert Lott, M.D.; William Rietkerk, M.D.; Jennifer Vickers, M.D.; Kathryn Russell, M.D.; and Bijan Safai, M.D., professor 
and chairman. Not pictured is resident James Highsmith, M.D.
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The biggest disconnect in pre­paring for a career in the health sciences may be how unhealthy 
the journey can be. Too little sleep, too 
much fast food and not enough exercise 
are the pillars of life for medical students 
and graduate students. That is, unless 
they are so committed to fitness that 
their success depends on it.
John Nunez, Izuchukwu Ibe and Andrea 
Love are such fitness­philes. They don’t 
jog or take the occasional Zumba class. 
They train for marathons, compete in 
semi­pro soccer tournaments and prac­
tice black belt judo. They would no 
more miss a workout than they would 
cut a class, clinic or lab.
JOHN NUNEZ, SOCCER 
School of Health Sciences and 
Practice
As John Nunez tells it, two things saved 
him during his first semester as a doc­
toral candidate in physical therapy: the 
camaraderie of classmates and playing 
semi­pro soccer. “It was the hardest 
academic semester of my life,” the  
second­year PT student says, recalling 
a schedule that included neuro science, 
physiology and exercise science. Then, 
two months before school started, he 
was invited to try out for the Cosmo­
politan League—the Cadillac of amateur 
soccer leagues. It was a fantasy come 
true for the lifelong soccer player, who 
had always dreamed of playing college­
level soccer (he played Division 1 at 
College of the Holy Cross) or going  
into medicine.
“I’m playing at a higher level than I ever 
thought I’d play,” says Nunez, who now 
competes among world class players. 
His level of commitment might seem 
incompatible with doctoral studies. 
Indeed, Nunez says some classmates 
scratch their heads when he closes his 
books and leaves for practice. Yet for 
this 27­year­old, who is both exuberant 
and calm, there is no choice. In the first 
place, playing soccer keeps him aca­
demically focused. “It keeps you on top 
of your school work,” he says. Second, 
being fit is critical for physical therapists, 
who often must lift patients heavier than 
themselves and are uniquely positioned 
to inspire patients toward greater levels 
of health. “As a medical professional, 
you should demonstrate fitness and 
good health to patients,” Nunez says.
John Nunez,  
Izuchukwu Ibe  
and Andrea Love: 
Student Athletes  
Compete to Stay  
Mentally and  
Physically Fit 
By Andrea Kott, M.P.H.
John Nunez 
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“ If we’re going to tell patients to be 
healthy, then we have to be healthy,” 
he says. “Just saying you can’t do it 
isn’t a reason not to do it.”
Nunez has always been fascinated by 
the human body and its capacity for 
endurance. Although he once envisioned 
following in the footsteps of his orthope­
dist father, his own athleticism sparked 
his interest in the more hands­on, pre­
ventive approach of physical therapy. 
“Once you get injured a few times and 
undergo PT, you realize how you can 
use your knowledge to be safe and  
prevent injuries,” he says. Conversely, 
Nunez the athlete is always thinking 
about pushing physical limits. “As a 
physical therapist, you always wonder  
if a patient is at risk. How far can they 
push themselves?”
Nunez lives to push himself. Twice a 
week at 9 p.m., after eight hours of 
school, he drives to Queens to prac­
tice with his team, the New York Greek 
Americans. The exhaustive workout 
includes more than two hours of fast 
runs, sprints and interval training, drills 
tailored to build lung endurance and  
the body’s ability to recover quickly.  
“It’s about [seeking] the maximum  
of what your body can do,” he says.  
He plays two games on weekends, 
although he tries not to compete when 
his schedule includes clinical rotations, 
because an injury could prevent him 
from performing necessary physical 
tasks. Throughout the year, Nunez 
keeps up with training and practices, 
picking up games with indoor soccer 
leagues at home in Fishkill, N.Y., playing 
club soccer with other students on 
campus, lifting weights in the College 
fitness center and training for marathons.
The regimen keeps this emerging physi­
cal therapist in top physical shape, dis­
ciplined and focused. Plus, it just feels 
good, he says, “knowing I can do some­
thing like that and still maintain the 
grades.” Not that he would have it any 
other way. “As an athlete, excuses don’t 
exist for you.”
IZUCHUKWU IBE, RUNNING
School of Medicine
Excuses don’t exist for Izuchukwu Ibe 
either, although the second­year medical 
student admits his runner’s discipline 
developed only recently. “The mental 
part of pushing myself was there, but 
not in running,” says the Nigerian native, 
who played soccer for SUNY Albany, 
where he entered as a freshman at age 
16. “I always told myself, ‘Running is 
boring, I’m never going to run past six 
miles.’” But last summer, just one month 
into his first year of medical school, the 
22­year­old traded his soccer cleats for 
running shoes to train for the New York 
City Marathon. Along the way, he dis­
covered he was capable of more than 
he ever knew.
Ibe had never run more than three or 
four miles a couple of times a week  
to stay in shape. Then he met Debra 
Gerson, M.D., medical director of the 
Open Door Family Medical Center, a 
College affiliated clinic. Dr. Gerson was 
his supervisor during a summer program 
that exposed high school students to 
the medical field. A cancer survivor, she 
described the thrill of running her first 
marathon. Her feat inspired him to give 
it a try.
At the beginning of his second year, 
with only three months to train and a 
mandate to raise at least $2,000 for a  
Izuchukwu Ibe
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sponsoring charity, Ibe harnessed his 
medical student’s mettle. He started  
running three to five days a week, and 
lengthened each run by one­ to three­
mile increments. Fortunately, his work­
outs provided a valuable respite from 
studying. “Training for the marathon  
was my getaway from school,” he says.
But school got hectic and by marathon 
day, Ibe had not managed to train beyond 
18 miles, the point in the actual race when 
his legs almost buckled. That’s when he 
noticed other runners. “I saw a runner 
with one leg, racers in wheelchairs, run­
ners who were overweight, skinny, young 
and old,” he says. They inspired him. 
Four hours and 38 minutes later, Ibe  
finished the race. He also raised $3,000 
for Shoe4Africa, which builds children’s 
hospitals in Kenya. “I crossed the finish 
line and I thought, ‘I’m signing up for 
another one.’”
As other runners have inspired Ibe, who 
is set on practicing orthopedics, so does 
he hope to inspire patients. “If we’re 
going to tell patients to be healthy, then 
we have to be healthy,” he says. “I said,  
‘I can’t run more than six miles’ and I  
ran 26. I said ‘I can’t raise $2,000’ and  
I raised $3,000. Just thinking you can’t 
do it isn’t a reason not to do it.”
ANDREA LOVE, JUDO
Graduate School of Basic Medical 
Sciences
For Ibe and Nunez, training for athletic 
competition is about staying mentally 
sharp, physically fit and pushing personal 
limits. For judo black belt Andrea Love,  
a Ph.D. candidate in the Department of 
Microbiology and Immunology, it is also 
about increasing productivity and releas­
ing stress. Working out is non­negotiable 
for Love, even if it means sacrificing a lit­
tle sleep. “You reach a saturation point,” 
she says of the long hours she spends in 
the lab. “If you take an hour­long break 
to do anything, it can really get you back 
on track.”
Judo puts Love back on track. Four to 
five nights a week, she drives to North 
Bergen, N.J., where she practices a  
repertoire of skills that include throwing 
opponents, pinning them down, chok ing 
them (to unconsciousness if they don’t 
forfeit the match) or twisting their elbow.
With her long dark braids, chic black 
eyeglasses and a tiny stud in her nose, 
Love, 24, doesn’t look like a judo cham­
pion, let alone a nationally certified coach 
with the U.S. Judo Association. She 
clearly gets a kick out of that. “Dude, I 
fight people,” she says, displaying her 
unmanicured nails. “If I leave practice 
and I don’t have any bruises, I feel like  
I didn’t work out hard enough.”
Growing up in Norwich, Conn., Love 
started studying judo at age 4. “I hated 
ballet,” she recalls. “I was a tomboy—
always in the woods, building tree houses, 
collecting bugs. I was a feisty little kid,” 
she says. She started competing at 5, 
was a nationally ranked champion by 15 
and a black belt one year later. Although 
injuries kept her off the competition cir­
cuit during her undergraduate years at 
SUNY Stony Brook, she is preparing to 
return. This means her days in the lab, 
where she studies the immune response 
to infection with Borrelia burgdorferi, the 
bacterium that causes Lyme disease, are 
especially long. But she doesn’t miss a 
workout, which typically includes running 
(she has run marathons and half­mara­
thons), strength training and practicing  
on the judo mat. If she can leave mid­
experiment to work out, she will, some­
times returning to the lab as late as 11 
p.m. to finish. “When you’ve been work­
ing on an experiment for two months 
and it fails, it’s really nice to beat up on 
somebody,” she kids. “It definitely helps 
my mood and productivity.” 
After she graduates in two years, Love 
hopes to work in the field of infectious 
disease for the Centers for Disease 
Control or the National Institutes of 
Health. Wherever she lands, she says 
she will keep practicing judo. “It’s an 
awesome full body workout and incredi­
ble stress relief.”  ■
 “ I was a tomboy, 
always in the 
woods, building 
tree houses, col-
lecting bugs. I 
was a feisty little 
kid,” she says.
Andrea Love
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Investigating  
Epilepsy: Calming the 
Electrical Storm
By Chirag Upreti
 Epilepsy is a debilitating neurological disorder that affects about one percent of the world’s population. In the brain, neurons communicate with one other at specialized junc­
tions called synapses. Electrical signals that travel down the 
presynaptic neurons release a chemical messenger, or neu­
rotransmitter, which then diffuses and activates its receptors 
on the post­synaptic neurons, leading to the generation of 
electrical signals in the postsynaptic neurons, thus success­
fully transferring the electrical information from one neuron to 
the other. The presynaptic mechanisms that may be altered in 
epilepsy remain poorly understood, though research from our 
lab suggests that epilepsy leads to both structural and func­
tional alterations. My current research examines prospective 
changes in these synaptic compartments, and whether they 
could serve as therapeutic targets for novel drugs.
The most common drug­resistant form of epilepsy is called 
mesial temporal lobe epilepsy (MTLE). My research has 
focused on the hippocampus, a part of the brain that can be 
severely damaged by MTLE. A few very limited studies have 
examined the functional properties of how neuronal properties 
are altered in epilepsy. In particular, I was interested in how the 
neurons may alter the secretion of the neurotransmitter in epi­
lepsy, by altering the recycling of the packets or vesicles into 
which they are packed. In the laboratory of Patric K. Stanton, 
Ph.D., professor of cell biology and anatomy and of neurology, 
the tools and the expertise—along with animal models that 
can robustly recapitulate the human disease—allowed me to 
focus on a precise question: Do the vesicles that contain the 
neurotransmitter recycle in a manner different than under nor­
mal circumstances?
Using live cell imaging and 2­photon microscopy of these sub­
cellular compartments called presynaptic terminals, we were 
able to demonstrate that the acute brain slices derived from 
epileptic animals showed greater vesicle fusion and recycling 
characteristics. This suggests that regions of the brain could 
secrete more of the excitatory neurotransmitter and thus lead 
to hyperexcitability and hypersynchronization of neurons, likely 
progressing to the epileptic state.
In collaboration with colleagues at the University of Texas (UT) 
Brownsville and UT Austin, we used transmission electron 
microscopy to determine persistent alterations in the ultra­
structure of these presynaptic terminals. Our work suggests 
that these synaptic terminals are persistently altered in struc­
ture and function in the pathophysiology of epilepsy and could 
also serve as therapeutic targets for novel drugs targeting 
intractable epilepsy.  ■
➤ CHIRAG UPRETI
Chirag Upreti has been studying the cellular and molecular mechanism of epilepsy, an interest that dates back to his witnessing a childhood friend suffer  
a seizure as they played a cricket match in his hometown of Nainital, India. His fascination with neuroscience grew as an undergraduate at Osmania 
University in Hyberabad, where he received a B.Sc., and at Panjab University in Chandigarh. He is a member of the American Epilepsy Society, and hopes 
to further his career with postdoctoral study in the field. At press time, he had just accepted a postdoctoral position in the lab of Nobel Prize winner Eric 
Kandel, M.D., at Columbia University.
Graduate Students
Explain It All
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Not All Sugars Are Created 
Equal: Effects of High 
Fructose Consumption  
on the Heart
By Elizabeth Kertowidjojo
T
he simple monosaccharide fructose has generated a 
controversy unlike any other sugar. A recent national 
health and nutrition examination survey found that 
Americans consume more than 10 percent of their caloric 
intake in the form of fructose, with adolescents consuming  
up to 15 percent.
The consumption of fructose, especially in the form of high 
fructose corn syrup (HFCS) is almost impossible to avoid in 
commercial food products. Parallel to the rise in fructose con­
sumption is an increase in obesity and the development of 
metabolic syndrome, a constellation of signs and symptoms 
including elevated plasma glucose, hypertension, dyslipidemia, 
insulin resistance, and central obesity. Studies have found a 
causal relationship between high fructose consumption and 
these conditions, although the mechanism behind this rela­
tionship remains unclear.
My work centers around the effects of high fructose consump­
tion on the cardiovascular system. Metabolic syndrome 
increases the risk of cardiovascular mortality more than three­
fold, and many of the harmful effects of fructose, such as 
hypertension, atherosclerosis and endothelial dysregulation, 
are directly related to metabolic syndrome. A link that is often 
found between lifestyle factors and cardiovascular dysfunction 
is inflammation and oxidative stress, specifically an elevated 
superoxide level. Superoxide is a free radical generated by a 
one­electron reduction of oxygen, and is mainly produced as 
an essential part of the immune process of pathogen killing. 
Elevated superoxide is often found in patients with detrimental 
lifestyle factors, such as smoking.
Among the harmful effects of superoxide is the scavenging  
of nitric oxide (NO), a gaseous signaling molecule essential  
to normal cardiovascular function. Discovered more than 20 
years ago, NO is best known for its role as a vasodilator and  
is still intensively investigated because of its numerous roles  
in signaling events and cardiac metabolism, many of which  
are essential to the cardiovascular system. We hypothesize 
that the detrimental effects of high fructose consumption stem 
from an increased level of superoxide, effectively reducing NO 
bioavailability and negatively affecting the heart.
In accordance with the literature, our study shows the devel­
opment of metabolic syndrome in fructose­fed animals, namely 
hypertension, insulin resistance and hyperurecimia. Fructose 
feeding alters cardiac substrate utilization and increases car­
diac work. The left ventricle of fructose­fed animals also dem­
onstrates an altered cellular metabolism, which is corrected 
with the addition of an exogenous NO donor. Incubation with 
tiron, the superoxide scavenger, or losartan, an angiotensin II 
receptor blocker, had a similar rescue effect.
Overall, our results have shown that high fructose consump­
tion increases the production of superoxide, lowering NO bio­
activity and inducing detrimental changes in the heart. We are 
currently conducting studies to further investigate the mecha­
nism behind this process, specifically determining the role of 
angiotensin II, a known activator of the superoxide­producing 
enzyme, NADPH oxidase.  ■
➤ ELIZABETH KERTOWIDJOJO
Elizabeth Kertowidjojo, originally from Jakarta, Indonesia, is an M.D./Ph.D. candidate in the laboratory of Thomas H. Hintze, Ph.D. ’80, professor and 
chairman of the Department of Physiology. After earning a B.S. in biochemistry and psychology from University of California, San Diego, in 2007, she 
joined NYMC as a medical student, and later the Graduate School of Basic Medical Sciences to pursue a joint M.D./Ph.D. degree. Ms. Kertowidjojo 
intends to pursue both a clinical and academic career, aiming to further the field of translational science.
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 Irina Ellison, Ph.D. ’05:
STAMPING OUT SMOKING AND BUILDING 
COMMUNITY 
By Andrea Kott, M.P.H.
If you smoke within sight of Irina Ellison, Ph.D. ’05, she will 
make a point of asking you to stop. She won’t lecture, judge or 
harass you. But she will take the time to explain that smoking 
endangers not just a smoker’s health but also the health of 
nearby nonsmokers. Not smoking around others is, therefore,  
a matter of personal and social responsibility.
“There are people who roll their eyes—usually the smokers,” 
Ellison says of the reactions to her crusade. “But when I get 
them one­on­one they open up and realize why there’s a fault  
in their logic in terms of exposure to secondhand smoke.”
Soft spoken and cheerful, Ellison does not seem audacious 
enough to ask a complete stranger to put out a cigarette. She 
definitely seems too mild­mannered to inform a pack of students 
that they cannot smoke on the campus of St. Francis College  
in Brooklyn, where she teaches cell and molecular biology. But 
the 31­year­old pathologist is fearless, and has done both. 
Moreover, she is determined to persuade people that personal 
acts have public consequences: 
that one person’s smoking can 
harm the health of many. 
Because of her activism, St. 
Francis College became a fully 
smoke­free campus in 2011. 
“We are the first New York City 
campus to go completely 
smoke free,” she says proudly.
Unlike some anti­smoking advo­
cates, Ellison’s campaign is  
not a backlash against a child­
hood spent choking on rela­
tives’ secondhand smoke. She 
has simply always been inter­
ested in disease prevention. Her 
dissertation research on the 
ways that different racial groups 
metabolize cigarette smoke—
and her finding that smoking 
puts some minorities at greater risk than whites—stoked her 
interest even more. “I’m interested in bridging basic science 
research with public health research to help people understand 
how their behaviors affect their health,” she says.
To hear Ellison make her case against smoking is to understand 
how one person can convince an entire community to make 
public health a top priority. “Smoking is the number­one cause 
of preventable disease in the world,” she says, revving up to 
recite a litany of smoking­related facts. “Cigarette smoke affects 
fertility and sexual performance. It is a huge source of free radi­
cals and air pollution. And cigarette butts are the most littered 
item in the world.” She lets the information sink in, then continues: 
“The number of people who die per year from secondhand 
smoke is much greater than the number of people who die in 
drunk­driving accidents. We have laws about drunk driving. 
For some reason the message has not hit home with second­
hand smoke.”
Ellison recognized the problem of secondhand smoke at St. 
Francis College when she arrived in 2006 and observed smokers 
congregating at the school’s only entrance and exit. “Not only 
was it not a good image for the college, but it was a public health 
concern for both the community and the college,” she said.
She convinced the administration to host a “Great American 
Smokeout,” which encourages smokers to give up the habit  
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 for a day. The event, co­sponsored by the American Cancer 
Society, featured workshops in hypnosis and stress reduction, 
karaoke singing (to test lung capacity) and the dispensing of 
free, six­week supplies of nicotine patches. The smokeout was 
such a success that the college recently hosted its fifth.
With each smokeout, approximately 30 people kick the habit, 
Ellison says, noting the modest but encouraging result. “It takes 
the average person 7 to 10 tries to quit smoking,” she says, 
clearly compassionate toward those struggling to kick the habit.
Compassion may be atypical among anti­smoking zealots, but 
Ellison believes it is critical for conveying her message. She 
doesn’t just tell people they should quit. She injects empathy 
into a broader message about the toll that smoking takes on the 
public health. “I don’t lecture that smokers should quit so much 
as explain how their smoking affects other people,” she said.  
“I thank people for moving away. I tell them, ‘You’re impacting 
the quality of people’s lives, and if you need resources about 
quitting smoking, let me know.’”
So far, a college in Virginia has contacted Ellison to ask for guid­
ance in making its campus smoke­free. Meanwhile, at St. Francis, 
her campaign has evolved from a lesson in public health to a 
model for community building, sparking conversations about 
the importance of promoting respect when opinions differ. To 
Ellison, not smoking is showing respect. “I talk to my students 
about it. We talk about why it’s important to respect the health 
of others.”
To some, Ellison is a godsend; to others, she is a challenge. 
Still, she is undaunted. “I’m about to go home and I will probably 
see someone smoking and get into a 45­minute conversation 
with them,” she says with a laugh. “This is my opportunity to 
help somebody.”  ■
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Alumni
Renee A. Perry, M.P.H. ’98, died 
June 27, 2011. She was 64.
Richard L. Blitz, M.D. ’88,  
died November 23, 2011. He was 51.
Dean H. Wasserman, M.D. ’75, 
died on May 21, 2012. He was 61.
Stephen R. Bolkin, M.D. ’71,  
died January 18, 2012. He was 68.
Robert C. Sabatelle, M.D. ’65,  
died January 13, 2012. He was 72.
Anthony Barone, M.D. ’64,  
died February 21, 2012. He was 73.
Leon I. Miller, M.D. ’64,  
died January 20, 2012. He was 79.
John J. Bucchiere Jr., M.D. ’62, 
died February 3, 2012. He was 75.
Howard B. Grunther, M.D. ’62, 
died January 11, 2012. He was 75.
William E. Tesauro, M.D. ’62,  
died November 7, 2011. He was 76.
R.P. Altman, M.D. ’61,  
died July 27, 2011. 
Nicholas A. Conforti, M.D. ’61, 
died November 1, 2011.
Joseph F. Kennedy, M.D. ’61,  
died January 24, 2012. He was 76.
William F. Flynn, M.D. ’60,  
died December 9, 2011.
Henry T. Grant, M.D. ’60,  
died December 17, 2011. He was 78.
Leo J. Greco, M.D. ’60,  
died December 24, 2011. He was 78.
Herbert H. Joseph, M.D. ’60,  
died August 1, 2011. He was 77.
Stephen T. Cogen, M.D. ’59,  
died February 15, 2012. He was 79.
Donald J. Bradley, M.D. ’56,  
died October 18, 2011. He was 83.
James C. Wright, M.D. ’56,  
died March 22, 2012. He was 81.
Alois Kallfelz, M.D. ’55,  
died February 16, 2012.
George W. Valentine, M.D. ’55,  
died July 2, 2011.
Richard Fisch, M.D. ’54,  
died October 23, 2011. He was 85.
Edward I. Henry, M.D. ’54,  
died in December 2011. He was 82.
John E. Aiken, M.D. ’53,  
died December 6, 2011. He was 87.
William P. Coats, M.D. ’53,  
died March 19, 2012. He was 90.
Irving N. Rubinstein, M.D. ’53,  
died August 30, 2011.
Carl J. Levinson, M.D. ’52,  
died November 21, 2011.
Arthur G. Sullivan, M.D. ’52,  
died December 12, 2011. He was 86.
Stanley A. Wanlass, M.D. ’52,  
died in 2012. He was 89.
Charles V. Tierney, M.D. ’51,  
died February 16, 2012.
Henry T. Uhrig, M.D. ’51,  
died November 17, 2011. He was 89.
Richard R. Bass, M.D. ’49,  
died January 12, 2012. 
Eugene E. Gaudet, M.D. ’46,  
died November 4, 2011.
Walter W. Kelley, M.D. ’44,  
died December 10, 2011. He was 96.
Joseph M. Andronaco, M.D. ’42,  
died February 11, 2012.
William Rubin, M.D. ’37,  
died November 4, 2011.
Faculty
Robert Goldstein, M.D., professor 
emeritus of medicine and former 
associate dean for student affairs, 
died on April 27, 2012 at the age of 
99. Dr. Goldstein joined the College 
faculty in 1961 and served as chair-
man of the Department of Medicine 
from 1969 until 1976. Although  
he retired in 1985, he continued 
serving on numerous committees 
until 2002. Dr. Goldstein’s true fer-
vor was his dedication to the medical 
students he served. Students dedi-
cated the yearbook to Dr. Goldstein 
five times, and in 1993 the graduat-
ing class established the Robert 
Goldstein, M.D., Society of Teachers 
Award to recognize exceptional and 
inspiring faculty members.
Harold Michal-Smith, M.D., former 
professor of pediatrics, died on 
December 20, 2011.
“ I’m interested in bridging 
basic science research 
with public health research 
to help people understand 
how their behaviors affect 
their health,” she says.
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Susan J. Blakeney, M.S. ’92, 
M.P.H. ’10: 
TWO DEGREES, TWO PATHS TO MAKING 
A DIFFERENCE 
By Cynthia A. Read
In May, Susan Blakeney flew to New Delhi, India, to begin six 
months as a Pfizer Global Health Fellow, working with Project 
HOPE’s India Diabetes Educator Project. That’s a long way, 
geographically and conceptually, from her education in bio­
chemistry and her career as a principal research scientist in 
Pfizer’s vaccine research program in Pearl River, N.Y. But, look­
ing back, she describes her life as a process of stones falling 
into place, one by one, all leading her to where she is now.
Blakeney has always been a questioner, eager to understand 
how things work. “Chemistry is like that—think of the Periodic 
Table,” she says. After receiving her B.S. in chemistry from 
Manhattan College in 1986, she got her first job at General 
Foods, working on a project seeking to genetically engineer a 
decaffeinated coffee bean. This introduction to biochemistry  
led her to her next position at Lederle Laboratories. There she 
has built a career in molecular biology, working on the develop­
ment of vaccines for polio, Norwalk virus, rotavirus and herpes 
simplex virus. She is currently with Pfizer’s 13V Pneumococcal 
Conjugate Vaccine program. Along the way, she went to New 
York Medical College for her M.S. in biochemistry and molecular 
biology and wrote her thesis on translation of poliovirus mRNA.
Meanwhile, Blakeney began to explore the world. In 2000,  
she went to Africa, first to climb Mount Kilimanjaro and then—
“having sufficiently tired myself out so I could relax in a vehicle” 
—on safari. That trip first sparked her interest in other cultures. 
But her dream was to go to the Far East, and her colleagues  
at Wyeth (which had acquired Lederle Laboratories) supported 
her taking a leave of absence to travel. In 2004, she visited 
Bhutan, Thailand, and Nepal, primarily trekking and visiting 
remote villages where health care was virtually nonexistent.  
“The experience really changed me,” she says. While she had 
once believed one needed medical training to help people,  
she realized she did not have to become a physician, which 
was not her natural bent. With the right training, she would be 
able to make a difference through educating people and giving 
them the tools to help themselves.
Soon after returning to the United States and to Wyeth, she 
went back to NYMC, this time in the School of Health Sciences 
and Practice in pursuit of an M.P.H. with a concentration in 
international public health. As part of the practicum she did a  
six­month internship in East Harlem, where she was trained  
as a community health worker doing diabetes education.  
“This internship was the best experience in my education,” she 
the00s
Kira Geraci-Ciardullo, M.D., 
M.P.H. ’07, was re-elected vice 
speaker of the Medical Society of 
the State of New York. She is also 
an adjunct assistant professor of 
pediatrics at NYMC.
the90s
Hurrah’s Nest: Memoirs of a Money 
Trader is the latest book written by 
Barbara A. Kennedy, M.P.H. ’96. 
Ms. Kennedy worked on Wall Street 
for more than 20 years prior to 
attending NYMC. The novel explores 
the bio/psycho/social/spiritual 
issues of relationships.
the80s
Victoria T. Crescenzi, M.D. ’89, 
retired from the U.S. Navy in 
September 2009 after 20 years  
of service. She is currently a devel-
opmental/behavioral pediatrician  
at Bremerton Naval Hospital in 
Washington State. She is married  
to Peter C. Carlo and they have  
two children.
The American Academy of Physical 
Medicine and Rehabilitation (PM&R) 
awarded Michael Fredericson, 
M.D. ’88, the Physiatric Association 
of Spine, Sports and Occupational  
Rehabilitation (PASSOR) Legacy Award 
and Lectureship. Dr. Fredericson is 
professor and director of PM&R 
sports medicine in the Department 
of Orthopedics at Stanford University 
and fellowship director for Stanford 
Sports Medicine.
Leona Borchert, M.D. ’87, is a 
medical director for oncology medi-
cal affairs at Boehringer Ingelheim 
Pharmaceuticals in Ridgefield, Conn. 
As a senior medical reviewer for the 
oncology division, she ensures that 
all oncology information, including 
television commercials that are 
directed toward health care providers 
and patients, is medically accurate 
and meets FDA regulations. 
Steven J. Litman, M.D. ’87, was 
named to Castle Connolly’s top  
doctors for pain management.
David Gross, M.D. ’84, his son 
Joshua A. Gross, a medical student, 
and two colleagues were co-authors 
of a paper, “Metastatic Hepatocellular 
Carcinoma to the Skin Staining Posi-
tive With HMB-45,” published in the 
February 2012 issue of the American 
Journal of Dermatopathology. 
Rebecca Steckel, M.D. ’83, reports 
her oldest son is enrolled at Ramapo 
College of New Jersey, her second 
son is in 11th grade at Hillel Yeshiva 
High School in Ocean Township, N.J., 
and her youngest daughter just 
started high school there. 
M il estones
ALUMNI ACHIEVEMENTS
In this section of Chironian, we publish Class Notes sent 
by our readers. News items should be brief, timely—and 
legible! Submit Class Notes online at www.nymc.edu/
alumupdate, or by mail to Alumni Relations, New York 
Medical College, 40 Sunshine Cottage Road, Valhalla, 
NY 10595. Be sure to look for us on Facebook and 
Twitter (@NYMC_tweets).
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William C. Reha, M.D. ’81, is  
president of the Virginia Urological 
Association, speaker of the house  
of the Medical Society of Virginia, 
member of the board of trustees  
at Strayer University and has a full-
time private practice in urology in 
Woodbridge, Va.
the70s
Nicholas Bonvicino, M.D. ’79, is 
leaving Horizon BCBS of New Jersey 
after 14 years as senior medical 
director to start a private health care 
consulting company, NB Healthcare 
Advisors, LLC, to assist providers  
in the development of accountable 
care entities. 
Scott Cutler, M.D. ’77, continues to 
practice adult psychiatry in Worcester, 
Mass., and New York City. His 
daughter, Beth Cutler Freedman, 
M.D. ’06, recently achieved board 
certification in general surgery and 
is currently a fellow in breast surgi-
cal oncology at Beth Israel Medical 
Center/St. Luke’s Roosevelt Hospital 
Center in New York.
Nicholas V. Polifroni, M.D. ’77, 
chief of orthopedic surgery at 
Norwalk Hospital in Connecticut, 
received the hospital’s Tracey Award 
for leadership, character, community 
service involvement and clinical skill.
Michael J. Bronson, M.D. ’76,  
was appointed vice chairman of the 
Department of Orthopedic Surgery at 
The Mount Sinai School of Medicine. 
Daniel Morhaim, M.D. ’75, is the 
author of The Better End: Surviving 
(and Dying) on Your Own Terms in 
Today's Modern Medical World, pub-
lished by Johns Hopkins University 
Press. Dr. Morhaim presents the 
case that choosing end-of-life care 
depends on accurate information 
and personal values. He writes, “The 
book is about empowerment, dignity 
and control in managing medical  
crises and end-of-life care.”
William Wickemeyer, M.D. ’75, 
was named Cardiovascular Services 
Physician Leader at Mercy Medical 
Center–Des Moines, where he is 
responsible for implementing key 
organization-wide strategies, pro-
grammatic decision making, and 
communication and collaboration 
with medical staff.
the60s
Richard Fogler, M.D. ’68, chair-
man emeritus of the Department of 
Surgery, chief medical officer and 
designated institutional official at 
Brookdale University Hospital and 
Medical Center, in Brooklyn, N.Y., 
writes, “The glimmer of retirement is 
in sight and the warmth of ‘Zayde-
hood’ is approaching.”
Morton Meltzer, M.D. ’65, is still 
working full-time in psychiatry  
but gave up family medicine and 
urgent care. 
Stephen T. Batthany, M.D. ’64, 
resides in Lake Worth, Fla., and is 
awaiting an appointment as assistant 
clinical professor of family medicine. 
He recently spoke with Ira Raff, 
M.D. ’64, and Robert Lieberman, 
M.D. ’62, and will attend the 50th 
reunion. 
Stanley Ostern, M.D. ’60, is hap-
pily retired in Santa Barbara and 
enjoying his 11 grandchildren. He 
underwent aortic valve replacement 
surgery several months ago and is 
happy to report that he is able to 
play tennis six days a week. “Not 
bad for someone who just had his 
77th birthday,” he writes. He is 
involved in a program that teaches 
troubled youth about the Holocaust, 
and he would enjoy hearing from 
classmates.
the50s
Ronald Pion, M.D. ’56, continues to 
offer strategic advice to early stage 
companies that use innovative and 
disruptive technologies.
says, “and had the greatest impact on my career and my aspi­
rations, along with the support of Dr. Murthy [Padmini Murthy, 
M.D., M.P.H., M.S., CHES, the school’s international health  
program director].”
Blakeney received her M.P.H. in 2010, after Wyeth was acquired 
by Pfizer, Inc. She soon learned of the Pfizer Global Health 
Fellows Program, which places people in short term volunteer 
assignments with international development organizations. It 
sounded like a perfect fit. Her experience with East Harlem 
community health education made her a good match for Project 
HOPE’s diabetes prevention and care initiative in India, which 
leads the world in the prevalence of the disease. She will remain 
there through October 2012, lending her expertise and learning 
about the culture. The project emphasizes the role of the edu­
cator in empowering patients, especially those at risk for the 
disease, to take responsibility for their daily care—a sustainable 
model of the kind Blakeney most admires.  ■
In 2004, she visited Bhutan, 
Thailand, and Nepal, primarily 
trekking and visiting remote 
villages where health care 
was virtually nonexistent. 
“The experience really 
changed me,” she says.
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Timothy Hsieh, M.D. ’98:
AN EASTERNER, NOW AT HOME  
IN OKLAHOMA
By Andrea Kott, M.P.H.
Tahlequah, Oklahoma, is not where Timothy Hsieh, M.D. ’98, 
expected to live after graduating from medical school. And, 
once he left, it is not where he expected to return. But between 
becoming a physician and raising a family, Dr. Hsieh found he 
needed balance, and that is what brought him back.
After completing his training in internal medicine and geriatrics 
in 2003, Dr. Hsieh moved to Tahlequah to work in a clinic at the 
W.W. Hastings Hospital, a 60–70 bed facility that is part of the 
Indian Health Service under the U.S. Department of Health and 
Human Services. The Cherokee Nation operates the hospital, 
which cares exclusively for Native Americans of all tribes.  
Dr. Hsieh had expected to stay for three years, under the terms 
of his National Health Service Corps scholarship, which requires 
one year of service in an underserved area for every year of 
financial support provided. And, he did. But he missed family 
back east, so in 2006 he accepted a private practice position in 
State College, Pennsylvania. Once there, although he was in the 
same time zone, he found the new job did not give him enough 
time to spend with family.
Moreover, he was spread too thin to be able to provide con­
tinuous, individual patient care. Thus, one year after leaving 
Hastings Hospital, Dr. Hsieh returned, and in 2010 he joined its 
four­person hospitalist team. As a hospitalist, Dr. Hsieh is able 
to address patients’ needs as they occur throughout the day—
faster than a primary care physician who visits only once a day 
or sees them briefly in a clinic. “In a clinic setting patients show 
up with chronic problems that require lifelong management,” he 
says. “If you have many patients waiting for you, you see them 
quickly and may not address them again until the next office 
visit. Hospitalists get satisfaction from seeing the results of fixing 
acute problems.”
Such continuity is critical for treating acute presentations of 
chronic medical problems like diabetes, hypertension, chronic 
obstructive pulmonary disease, congestive heart failure and 
coronary artery disease, which are prevalent in the Native 
American population and require ongoing monitoring. As part of 
the rapid response team, hospitalists can also respond to acute 
and sometimes urgent life­threatening situations.
Following cases from admission to discharge allows hospitalists 
to develop good rapport with patients, which is especially 
important in the Native American community, whose traditions 
and beliefs may foment distrust of Western medical care. 
“Language could be a hindrance to educating Native Americans 
about why we’re giving them medicine,” Dr. Hsieh says, adding, 
“I’ve had patients who seek their own healers.”
It has been nearly a decade since Dr. Hsieh first arrived at 
Hastings Hospital, and in that time he has found the balance 
between work and family life. His every­other­week schedule 
allows him quality time with daughter Lauren, 8, and son Daniel, 
2. He has room for professional growth and recently became a 
board­certified sleep specialist. He also has time to teach medi­
cal students and residents at Oklahoma State University for 
Health Sciences, where he is an adjunct clinical assistant pro­
fessor of internal medicine. Plus, Tahlequah is an affordable 
place to live and a great place to raise children, he says, adding, 
“I would never in a million years think I’d be in Oklahoma.” Not 
only there, but there and back again—just like home. ■
“ The Cherokee Nation  
operates the hospital, which 
cares exclusively for Native 
Americans of all tribes.”
P
ho
to
 c
ou
rt
es
y 
of
 C
he
ro
ke
e 
N
at
io
n 
C
om
m
un
ic
at
io
ns
.
32 : :  Spring/Summer 2012
ALUMNI 
ASSOCIATION 
BOARD OF 
GOVERNORS
Officers
Eileen (Lee) M. Dieck, M.D. ’86
President
Henry I. Saphier, M.D. ’61
President-Elect
Charles W. Episalla, M.D. ’88
Vice President
John R. Addrizzo, M.D. ’64
Treasurer
Joseph L. Giamelli, M.D. ’02
Secretary
Robert J. Furey, M.D. ’62
Archivist
Elected Governors
Class of 2014
Thomas D. Cerabona, M.D. ’82
John M. Cosgrove, M.D. ’83
Class of 2013
Roger S. Madris, M.D. ’79
Thomas J. Pacicco, M.D. ’85
Class of 2012
Patricia A. Barry, M.D. ’83
Matthew A. Bank, M.D. ’95
George C. Shapiro, M.D. ’88
Faculty Governor
Leonard J. Newman, M.D. ’70
Past Presidents
Dennis J. Allendorf, M.D. ’70
Michael A. Antonelle, M.D. ’62
Saverio S. Bentivegna, M.D. ’50
Joseph F. Dursi, M.D. ’59
Louis E. Fierro, M.D. ’60
Rita F. Girolamo, M.D. ’51*
Cyrille R. Halkin, M.D. ’45*
Henry P. Leis Jr., M.D. ’41*
David T. Mininberg, M.D. ’61
E. Edward Napp, M.D. ’33*
Christopher F. X. Riegler, M.D. ’88
Seymour Schlussel, M.D. ’51*
Lawrence B. Slobody, M.D. ’36*
Martin L. Stone, M.D. ’44
Paul Tartell, M.D. ’52*
Member Emeritus
Phillip A. Marraccini, M.D. ’50
*Deceased
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1
PHOTOS
1:  The Class of 1962.
2:  Medal of Honor winners Robert J. Belsole, M.D. ’69, and 
Eileen Dieck, M.D. ’86, with Edward C. Halperin, M.D., 
M.A., the College’s new chancellor and CEO.
3:  Mickey and Henry Saphier, M.D. ’61, president-elect of 
the Alumni Association Board of Governors.
4:  The Class of 1987.
5:  Eileen Dieck, M.D. ’86, left, Henry Saphier, M.D. ’61, and 
Joseph F. Dursi, M.D. ’59 (right), with winners of the 
2012 Alumni Endowed Scholarships.
6:  Proud parents Patricia Barry, M.D. ’83, and John 
Cosgrove, M.D. ’83, with their daughter Susan Cosgrove, 
School of Medicine Class of 2012.
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